Author: Anders Bjers

Denmark has Joined the Call on AMR Diagnostics and Surveillance

Anders BjersNews and press

We are very happy to share with you that Denmark has joined the JPIAMR joint call on AMR diagnostics and surveillance.

The total budget for the call is now 20.06 M €.

If you have questions regarding the call, please contact the Call Secretariat via e-mail: JPIAMRCall2019@dlr.de

With more than 40 countries included in the call, it now spans from Europe to Canada to the major part of African countries and beyond Asia with China, India and many other Asian countries included. This creates a host of opportunities for collaboration and truly shows the global reach and capacities of JPIAMR. The full list of criteria to apply for the call is found on the call page.

The call closes on February 18, 2019. So, we encourage everyone to keep sharing the links on Twitter, Facebook and LinkedIn about the call, in order to include even more researchers as applicants. Also, we are keen to spread the information in groups on WhatsApp.

Startup Workshop for Funded Networks

Anders BjersNews and press

A startup workshop will be taking place in the Netherlands on February 19-20 to kickoff activities for all Networks from the two Transnational Network calls launched by JPIAMR in 2018: JPIAMR Network Call on Surveillance and
JPIAMR-VRI Network Call 2018

Workshop Objectives

The workshop aims to explore opportunities for future research collaborations, synergies and partnerships both between applicants and with external partner, between networks within each call, and between calls if appropriate. In addition to this, the workshop aims to create an overview of network activities within the funding period to enhance alignment and coordination, and support communication of network outputs by the JPIAMR.

Eighteen networks (ten in surveillance and eight in JPIAMR-VRI) have been funded with approximately €50,000 to enhance resource alignment and efforts in the field of AMR surveillance and to help build the JPIAMR-VRI. Two of the funded networks in each of the calls received additional funding to coordinate this start-up meeting. A final workshop is also planned for April 2020.

Trailer – Overview of AMR science policy and funding

Anders BjersNews and press

JPIAMRs Laura Marin presents the article published in the journal Trends in Microbiology on AMR, science policy, innovation, public health and funding. The article summarises the many recent AMR projects (JPIAMR, TATFAR, CARB-X, GARDP, ND4BB , G7/ G20 Health Ministers, and more) and is a good general reference and entry to the AMR community. The article is co-authored by Arjon Van Hengel (Directorate-General for Research & Innovation, European Commission) and Laura Marin (JPIAMR).

 

Kick-off: ECRAID, the European Clinical Research Alliance on Infectious Diseases

Anders BjersNews and press

JPIAMR will be participating in a high-level meeting in Brussels, on January 17th 2019, on the development of ECRAID, the European Clinical Research Alliance on Infectious Diseases. ECRAID envisages a European-wide sustainable clinical research organization for infectious diseases and AMR, antimicrobial resistance. Laura Marin, JPIAMR Head of Secretariat, will participate in panels, etc.

ECRAID’s vision is to create a coordinated and permanent European clinical research infrastructure for clinical research on infectious diseases.  The focus is on two major challenges: emerging infectious diseases with epidemic or pandemic potential, caused by new or re-emerging pathogens, and AMR (antimicrobial resistance). ECRAID will be enable clinical research to be faster and easier having rapid access to and knowledge of developed clinical and laboratory sites. Trials will be conducted continuously to expand on knowledge and experience.

The organisations aim is to protect public health by generating evidence in order to improve diagnosis, prevention, and treatment.  The ECRAID mission is to facilitate and develop world class research to protect citizens of Europe against AMR (antimicrobial resistance) and infectious diseases, over the long term. Professor Herman Goossens together with epidemiologist Marc Bonten, is the project coordinators of ECRAID.

There will be panel discussions with clinical research networks, preclinical research networks, pharmaceutical and diagnostic companies,
SMEs, etc. Together with speakers such as EU Commissioner Carlos Moedas, Herman Goossens, Marc Bonten, Magda Chlebus, Executive Director, Science Policy & Regulatory Affairs, EFPIA and Jeremy Farrar, Director of the Wellcome Trust, and others. This is a closed meeting.

One Health in Focus when EU-JAMRAI Interviews JPIAMRs Laura Marin

Anders BjersNews and press

In the latest newsletter form EU-JAMRAI, Laura Marin, JPIAMRs Head of Secretariat, is interviewed. The topic is international AMR initiatives and the need of a One Health Approach.

This fits well with JPIAMR’s focus. Our Strategic Research and Innovation Agenda is based on a One Health approach, and the initiatives created by JPIAMR is often centered on global collaboration and coordinating public AMR funding.

The interview was made earlier this year at ECCMID in Spain.

JPIAMR is Partnering on the Call to Action 2018 Conference in Ghana

Anders BjersNews and press

This is the second global conference on AMR that Wellcome Trust is co-hosting, this time together with the governments of Ghana and Thailand and the United Nations Foundation. The conference takes place in Accra on November 19-20. The Call to Action on AMR 2018, is organised in partnership with the Inter-Agency Coordination Group (IACG) on Antimicrobial Resistance, bringing together stakeholders and pioneering projects.

The Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) is a growing global collaborative platform, with 27 nations working to curb antibiotic resistance (AMR) with a One Health approach. In that spirit, being a partner is a natural fit.

At the conference, JPIAMR is putting focus on the recently pre-announced AMR Call on Diagnostics and Surveillance. Being included, as a partner in the program and via activities within the conference, the call is communicated together with facts about JPIAMR.

Follow the conference via #CalltoAction18 on Twitter.

JPIAMR Highlighted in G20 Health Ministers Joint Declaration

Anders BjersNews and press

The 2018 G20 Health Ministerial Meeting in Mar del Plata, Argentina, concluded on October 4th with a joint declaration on concrete health policy proposals.

The document considers health a key aspect for sustainable development and calls for a further strengthening health systems. It also recommends concrete actions to address global issues such as antimicrobial resistance, and with commitments for “increasing the level of awareness on the prudent and responsible use and disposal of antibiotics of all healthcare providers, veterinarians, farmers and food producers and of the general public.”

In the declaration, the G20 also mentions JPIAMR together with GARDP, UNITAD, CARB-X and the TB-Alliance, welcoming the work of these leading international initiatives.

Please view the full declaration here.

Coming Soon: Call on Diagnostics and Surveillance

Anders BjersNews and press

Antimicrobial resistance (AMR) has become one of the major global health and development challenges of the 21st century. The threat of AMR is particularly high in resource-limited and high-risk settings. This is linked to weak human and animal health systems; diverse means of food production, processing and consumption; food safety and food security; water, hygiene and sanitation challenges; and the global movement of people and goods.

In response to these challenges, the JPIAMR will launch a joint transnational call for proposals for innovative research projects on new or improved diagnostics and surveillance strategies, tools, technologies and methods. These research projects should address diagnosis of AMR infections in clinical and veterinary settings, or the emergence, surveillance, and/or detection of AMR in humans, animals and the environment. This Call will support research projects that also have the potential for impact in areas where the risk and burden of AMR is greatest, e.g. in LMIC settings in Asia and Africa. Projects are encouraged to use a One Health approach where relevant. The projected call budget is approx. 20 million Euro.

Scope of the call

Projects should aim to either:

  1. Develop strategies, tools, technologies, and methods for the detection, monitoring, profiling and/or surveillance of antimicrobial resistance and dynamics leading to resistance.
  2. Study ways to facilitate and implement the uptake and use of existing strategies, tools, technologies, and/or methods for the detection, monitoring, profiling and surveillance of antimicrobial resistance and dynamics leading to resistance.
Eligibility

List of participating countries is provisional.
Consortia of eligible scientists from participating JPIAMR member countries and eligible countries in Africa and Asia may apply to this call. Full eligibility criteria will be included in the Call launch. Participating JPIAMR member countries include Canada, Czech Republic, Finland, France, Germany, Israel, Italy, Latvia, Norway, Poland, Romania, Spain and  Sweden. Consortia must include a minimum of three and a maximum of six project partners from at least three eligible countries.

The Netherlands has the intention of joining the call but no funding is guaranteed yet. Updates on the progress will be shared.

Expected timeline
  • November 2018 – Pre-announcement of the call
  • December 2018 – Publication of the call
  • February 2019 – Submission deadline for pre-proposal
  • April 2019 – Full proposal invitations sent to project coordinators
  • June 2019 – Submission deadline for full proposals
  • October/November – Final funding decision announced
  • December 2019/ Early 2020 – Project start

Download as pdf

Open consultation: JPIAMR is updating the Strategic Research and Innovation Agenda (SRIA)

Anders BjersNews and press

Update of the JPIAMR Strategic Research and Innovation Agenda 2018

The JPIAMR recognises that innovation is critically important in the field of AMR, as there is a strong need of new therapeutics, diagnostics, and innovative infection prevention and intervention measures. The JPIAMR is therefore currently refreshing its JPIAMR Strategic Research Agenda (SRA) to take account of recent research findings and to extend the JPIAMR SRA into a Strategic Research and Innovation Agenda (SRIA).

The research objectives and research priorities of the JPIAMR SRIA are now open for public consultation. We welcome feedback on the research topics from the AMR community from the 9th of July to the 15th of September (12.00 CET).

For more information and instructions for providing feedback, please click here.